晨光新材(605399.SH):擬投1.5億元建設“年產 2.3萬噸特種有機硅材料項目”
格隆匯11月17日丨晨光新材(605399.SH)公佈,為進一步延伸產業鏈,豐富產品線,提高公司競爭力,公司擬在江西省九江市湖口縣金砂灣工業園向陽路8號投資建設“年產2.3萬噸特種有機硅材料項目”,該項目總投資金額為1.5億元人民幣。
項目建設內容:3-辛酰基硫代丙基三乙氧基硅烷5000t/a、辛基三氯硅烷5000t/a、六甲基二硅氮烷3000t/a、甲基硅酸2000t/a、甲基苯基二氯硅烷4000t/a、苯基三氯硅烷2000t/a、氣凝膠2000t/a的生產裝置及其相應配套設施的投資建設。
項目建設工期:項目計劃在2年內完成建設。
Follow us
Find us on
Facebook,
Twitter ,
Instagram, and
YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the
uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!

Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.